Dated: July 25, 2022 To: Darlene Deptula-Hicks Crimson Consulting, LLC Dear Darlene:Waiver and Release Agreement • July 25th, 2022 • Invox Pharma LTD • Pharmaceutical preparations • Massachusetts
This letter memorializes an arrangement relating to your service with F-Star Therapeutics Inc., a Delaware corporation (the “Company”), that is being offered to you in connection with the transactions contemplated in that certain Agreement and Plan of Merger, entered into as of June 22, 2022, by and among invoX Pharma Limited, a private limited company organized under the laws of England and Wales (“Parent”), Fennec Acquisition Incorporated, a Delaware corporation and a direct wholly-owned subsidiary of Parent (the “Purchaser”), and the Company, pursuant to which Parent will acquire all of the issued and outstanding stock of the Company pursuant to a cash tender offer and, thereafter, the Purchaser will be merged with and into the Company, with the Company continuing as the surviving corporation in the merger and as a wholly-owned subsidiary of Parent (the “Transaction”), which is expected to occur in 2022 (the “Closing”).
Incentive AwardInvox Pharma LTD • July 25th, 2022 • Pharmaceutical preparations
